Hydroxychloroquine-Promoting COVID Study Retracted

Nature magazine reports that “A study that stoked enthusiasm for the now-disproven idea that a cheap malaria drug can treat COVID-19 has been retracted — more than four-and-a-half years after it was published.”

Researchers had critiqued the controversial paper many times, raising concerns about its data quality and an unclear ethics-approval process. Its eventual withdrawal, on the grounds of concerns over ethical approval and doubts about the conduct of the research, marks the 28th retraction for co-author Didier Raoult, a French microbiologist, formerly at Marseille’s Hospital-University Institute Mediterranean Infection (IHU), who shot to global prominence in the pandemic.

Three of the study’s co-authors had asked to have their names removed from the paper, saying they had doubts about its methods, the retraction notice said.

More…

Nature includes this quote from a scientific-integrity consultant in San Francisco, California. “This paper should never have been published — or it should have been retracted immediately after its publication.”